Isières, Belgium

Sylvie Defrère

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Botalys Sa. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvie Defrère. Retrieved from https://idiyas.com/inventor/sylvie-defrere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sylvie Defrère: Innovator in Medicinal Applications

Introduction: Sylvie Defrère is a notable inventor based in Isières, Belgium. She is currently associated with Botalys SA, where she contributes to the development of innovative medicinal solutions. Despite having no granted patents to her name, her work in the field of medicinal compositions and implants showcases her dedication to advancing healthcare.

Latest Patent Applications: Sylvie Defrère has filed several patent applications, including "GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENT." This invention pertains to a composition, a kit, and preparation thereof, which is intended for use as a medical or therapeutic substance. The composition comprises a rare ginsenoside, a ginsan, and a gintonin, with specific ratios to enhance its efficacy. Another significant application is "IMPLANT HAVING A CORE AND A TUBE ENCASING THE CORE." This invention relates to an implant that includes a core material made of polydimethylsiloxane or hydrogel polymer, encased in a tube made of ethylene vinyl acetate polymer or hydrogel polymer. The implant is designed for use as a medicament, particularly in the treatment of endometriosis.

Conclusion: Sylvie Defrère's innovative spirit and her contributions to medicinal applications highlight her role as a significant figure in the field of healthcare innovation. Her ongoing work promises to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…